Close Menu
Journal of Pharmacology and Pharmacotherapeutics
    Browse
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Past Issues
    • About
      • About Journal
      • Editorial Board
      • Bibliographic Listings
    • For Authors
      • Submission Guidelines
      • Submit Article
    • Contact
    Facebook X (Twitter) Instagram
    Journal of Pharmacology and PharmacotherapeuticsJournal of Pharmacology and Pharmacotherapeutics
    • Journal Homepage (SAGE)
    • Submission Guidelines
    Facebook X (Twitter) Instagram
    Submit
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Past Issues
    • About
      • About Journal
      • Editorial Board
      • Bibliographic Listings
    • For Authors
      • Submission Guidelines
      • Submit Article
    • Contact
    Journal of Pharmacology and Pharmacotherapeutics
    Home»Uncategorized»Management of Lumbar Canal Stenosis (Katigraha) with Ayurvedic Modalities: A Case Report
    Uncategorized

    Management of Lumbar Canal Stenosis (Katigraha) with Ayurvedic Modalities: A Case Report

    February 28, 20252 Mins Read
    Share
    Facebook Twitter Email

    Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print.
    Background: Lumbar canal stenosis (LCS) is a degenerative spinal condition causing narrowing of the spinal canal, leading to nerve compression. Symptoms include pain, stiffness, tingling, numbness, and difficulty walking, which worsen with standing and improvement with sitting. Conventional treatments offer symptomatic relief, while surgery carries risks and a high recurrence rate. Ayurveda provides a holistic, non-surgical approach through Shodhana (purification) and Shamana Chikitsa (palliative care). Purpose: This study evaluates the effectiveness of Ayurvedic therapies, including Panchakarma and oral medications, in managing lumbar canal stenosis. Methods: A 68-year-old male presented with lower back pain radiating to both legs, tingling, numbness, and difficulty walking for nine months following a road traffic accident. He underwent an 8-day Panchakarma therapy, including Sarvanga Snehana and Swedana, Kati Basti, and Yoga Basti, which included Matra Basti and Niruha Basti along with oral medications. Results: After 8 days treatment, the patient experienced significant symptom relief, improved mobility, and enhanced ability to perform daily activities independently. Conclusion: This case highlights the effectiveness of Ayurvedic therapies in managing LCS, suggesting Panchakarma and oral medications as a viable non-surgical alternative. Further research on larger populations is needed to validate these findings.

    Read Original Source

    Previous ArticleClinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
    Next Article Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models

    Related Articles

    Associations Between Therapeutic Drug Monitoring Indications and Plasma Concentrations in Epilepsy Management: Insights from a Tertiary Care Hospital

    Uncategorized

    A Nasal Gel Formulation of Ubrogepant Nanoparticles for Enhanced and Rapid Brain Delivery in the Treatment of Migraine

    Uncategorized

    Optimizing Geriatric Prescriptions: Development, Validation, and Pilot Testing of Novel Quality Assessment Tool

    Uncategorized
    Read Now
    Uncategorized

    Associations Between Therapeutic Drug Monitoring Indications and Plasma Concentrations in Epilepsy Management: Insights from a Tertiary Care Hospital

    June 22, 2025

    Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundEpilepsy affects around 70 million people worldwide,…

    A Nasal Gel Formulation of Ubrogepant Nanoparticles for Enhanced and Rapid Brain Delivery in the Treatment of Migraine

    June 21, 2025

    Optimizing Geriatric Prescriptions: Development, Validation, and Pilot Testing of Novel Quality Assessment Tool

    June 5, 2025
    Editor picks

    Development and Validation of a Robust LC-MS/MS Method for Quantitation of a Novel Kinase Inhibitor, Ritlecitinib, in Rat Plasma: Application in Pharmacokinetic Study

    February 18, 2025

    DNA Damage Underlies the Cytotoxic and Apoptotic Effects of Selected Ethiopian Medicinal Plants against Cancer Cell Lines

    February 18, 2025

    WITHDRAWN – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction

    February 18, 2025
    About Journal
    About Journal

    The Journal of Pharmacology and Pharmacotherapeutics (JPP) is an open access, peer-reviewed journal that publishes high-quality articles pertaining to basic research and clinical studies in the domains of Pharmacology and Pharmacotherapeutics.

    We're accepting new partnerships right now.

    Email Us: editor.jpp@phcog.net

    Facebook X (Twitter) RSS
    Our Picks

    Development and Validation of a Robust LC-MS/MS Method for Quantitation of a Novel Kinase Inhibitor, Ritlecitinib, in Rat Plasma: Application in Pharmacokinetic Study

    February 18, 2025

    DNA Damage Underlies the Cytotoxic and Apoptotic Effects of Selected Ethiopian Medicinal Plants against Cancer Cell Lines

    February 18, 2025

    WITHDRAWN – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction

    February 18, 2025
    Stay Connected

    Contact Editor-In-Chief
    Editor, Journal of Pharmacology and Pharmacotherapeutics
    Manuscript TechnoMedia LLP,
    #9, Vinnse Tower, Wheeler Road Extn.
    St. Thomas Town, 560084, Bangalore, INDIA
    Email: editor.jpp@phcog.net


    • Home
    • Site Map
    © 2025 JPharmacol.com Designed & Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.